Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation

被引：0
|
作者：
Grisetti, Luca [1 ,2 ]
Saponaro, Anna Alessia [1 ,2 ]
Sukowati, Caecilia [1 ,3 ]
Bonazza, Deborah [4 ]
Giacomello, Emiliana [5 ]
Tarchi, Paola [6 ]
Croce, Lory Saveria [1 ,5 ,7 ]
Palmisano, Silvia [5 ,7 ]
Anfuso, Beatrice [8 ]
Rosso, Natalia [1 ]
Giraudi, Pablo [1 ]
Tiribelli, Claudio [1 ]
Pascut, Devis [1 ]
机构：
[1] Fdn Italiana Fegato ONLUS, Trieste, Italy
[2] Univ Trieste, Dept Life Sci, Trieste, Italy
[3] Natl Res & Innovat Agcy Indonesia BRIN, Eijkman Res Ctr Mol Biol, Jakarta, Indonesia
[4] ASUGI, Surg Pathol, Trieste, Italy
[5] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[6] ASUGI, Surg Clin, Trieste, Italy
[7] ASUGI, Liver Pathol Clin, Trieste, Italy
[8] ICGEB, Trieste, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-516-YI
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 50 条
  • [1] The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hepatocarcinogenesis
    Grisetti, L.
    Saponaro, A. A.
    Sukowati, C. H. C.
    Tarchi, P.
    Croce, L. S.
    Palmisano, S.
    Rosso, N.
    Giraudi, P. J.
    Anfuso, B.
    Tiribelli, C.
    Pascut, D.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S219 - S220
  • [2] Programmed death-ligand 1 expression in the immune compartment of colon carcinoma
    Yilmaz, Osman
    Pankaj, Amaya
    Neyez, Azfar
    Rickelt, Steffen
    Taylor, Martin
    Lang, Evan R.
    Leijsen, Lieve
    Dinaux, Anne
    Shroff, Stuti G.
    Crotty, Rory
    Zhang, M. Lisa
    Cerda, Sandra
    Zhao, Qing
    Ferrone, Cristina
    Ting, David T.
    Patil, Deepa T.
    Yilmaz, Omer
    Berger, David
    Deshpande, Vikram
    MODERN PATHOLOGY, 2022, 35 (11) : 1740 - 1748
  • [3] Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma
    Shao, Yu-Yun
    Hsieh, Min-Shu
    Lee, Yi-Hsuan
    Hsu, Hung-Wei
    Wo, Rita Robin
    Wang, Han-Yu
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    HELIYON, 2024, 10 (14)
  • [4] Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma
    Montasser, Ahmed
    Beaufrere, Aurelie
    Cauchy, Francois
    Bouattour, Mohamed
    Soubrane, Olivier
    Albuquerque, Miguel
    Paradis, Valerie
    HISTOPATHOLOGY, 2021, 79 (01) : 36 - 46
  • [5] Programmed Death Ligand 1 Expression in Micropapillary Urothelial Carcinoma of the Bladder: Role for Immune Checkpoint Inhibitors
    Goodman, Abigail
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2018, 98 : 345 - 345
  • [6] Programmed Death Ligand 1 Expression in Micropapillary Urothelial Carcinoma of the Bladder: Role for Immune Checkpoint Inhibitors
    Goodman, Abigail
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2018, 31 : 345 - 345
  • [7] Programmed death-ligand 1 expression in carcinoma of unknown primary
    Kim, Hye Min
    Koo, Ja Seung
    BMC CANCER, 2024, 24 (01)
  • [8] PROGRAMMED DEATH-LIGAND 1 INHIBITORS: A SAFER IMMUNE CHECKPOINT INHIBITOR FOR THE KIDNEYS
    Manohar, Sandhya
    Elsherbiny, Hisham
    Herrmann, Sandra
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 701 - 701
  • [9] Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
    Lu, Li-Chun
    Lee, Yi-Hsuan
    Chang, Chun-Jung
    Shun, Chia-Tung
    Fang, Chih-Yeu
    Shao, Yu-Yun
    Liu, Tsung-Hao
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    LIVER CANCER, 2019, 8 (02) : 110 - 120
  • [10] The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma
    Wotman, Michael
    Herman, Saori W.
    Costantino, Peter
    Tham, Tristan
    LARYNGOSCOPE, 2020, 130 (11): : 2598 - 2606
12345